A new and interesting angle on the vitamin D story is emerging from research on weight gain in older women. The vitamin, it seems, is an important metabolic signal that indirectly regulates the propensity to store fat.
Methylenetetrahydrofolate reductase (MTHFR) is one of the most important enzymes in human physiology, having influence on at least as many biochemical processes as it has syllables in its name. Deficiencies in this enzyme increase the risk of CVD, several types of cancer, congenital defects, and inflammatory bowel disease. Fortunately, deficiencies are correctable with targeted supplementation.
People with metabolic syndrome who add a soy-based "medical food" to a low-glycemic load Mediterranean-style diet can push the cardiometabolic benefits well beyond what is obtainable with the diet alone.
Sublingual immunotherapy is a safe, highly effective alternative to injection-based treatments for managing allergies. Moreover, it enables primary care physicians to treat patients that they are currently referring out to specialists.
Despite the Institute of Medicine's recent report, many nutrition-minded oncologists believe high-dose vitamin D supplementation—upwards of 4,000 IU/day—has potential to markedly reduce risk of primary breast cancer as well as breast cancer recurrence, with minimal risk of toxicity.
The Institute of Medicine’s Nov. 30 consensus statement claiming most Americans do not need supplemental vitamin D—a position that runs counter to the views of many clinicians and researchers⎯has some folks wondering if committee members had preexisting biases or vested interests against supplementation.
It turns out that at least two members of the committee hold patents on synthetic vitamin D analogs in development or already on the market as prescription drugs, and significant relationships with companies involved in vitamin D drug development.
The problem with most medical weight loss programs is that they focus too much on weight loss and not nearly enough on overall health. Somae Health is a new 12-week, medically guided weight management program that begins with restoration of healthy gastrointestinal function.